Overview

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose and (primary) objectives of this study are to evaluate the efficacy, safety, and tolerability of TS-022 in adults with atopic dermatitis who have moderate to very severe pruritus (itching), following a 28-day regimen of twice-daily topical application.
Phase:
Phase 2
Details
Lead Sponsor:
Taisho Pharmaceutical R&D Inc.